These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 17340970)

  • 1. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.
    Staub D; Jonas N; Zellweger MJ; Nusbaumer C; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor.
    Kurz K; Voelker R; Zdunek D; Wergeland R; Hess G; Ivandic B; Katus H; Giannitsis E
    Clin Res Cardiol; 2007 Mar; 96(3):152-9. PubMed ID: 17180576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides.
    Foote RS; Pearlman JD; Siegel AH; Yeo KT
    J Am Coll Cardiol; 2004 Nov; 44(10):1980-7. PubMed ID: 15542280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
    Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
    Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of N-terminal pro B-type natriuretic peptide levels after symptom-limited exercise to baseline and ischemia levels.
    van der Zee PM; Verberne HJ; van Spijker RC; van Straalen JP; Fischer JC; Sturk A; van Eck-Smit BL; de Winter RJ
    Am J Cardiol; 2009 Mar; 103(5):604-10. PubMed ID: 19231320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
    Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.
    Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W
    Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of changes in B-type natriuretic peptides to detect ischemia in selected patients.
    Staub D; Jauslin D; Freidank H; Taegtmeyer A; Breidthardt T; Zellweger MJ; Mueller-Brand J; Christ M; Mueller C
    Int J Cardiol; 2009 Jul; 136(1):40-6. PubMed ID: 18632168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
    Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
    Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
    Skrzypek A; Nessler J
    Przegl Lek; 2014; 71(7):378-83. PubMed ID: 25338333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
    Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
    Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
    Hamano K; Abe M; Komi R; Kobayashi S
    Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.
    Weber M; Dill T; Arnold R; Rau M; Ekinci O; Müller KD; Berkovitsch A; Mitrovic V; Hamm C
    Am Heart J; 2004 Oct; 148(4):612-20. PubMed ID: 15459591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia.
    De Greef J; Funk M; Vermaak WJ; Perumal NS; Libhaber CD; Vangu MD
    Cardiovasc J Afr; 2008; 19(5):264-7. PubMed ID: 18997988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.